AI App Detects Skin Cancer with 99.8% Accuracy, Slashing NHS Wait Times
Derm AI, already proven on 230,000 NHS patients, now works on any smartphone, enabling pharmacy and GP-based skin checks that could cut the backlog of dermatology referrals.
Cross-Sector entity
Of the tracked stories, 3 of 3 also mention Derm AI, the most common co-covered peer. ai-models accounts for 1 of the 3 tracked stories, while 2 other categories carry the remainder. The tracked stories average 2 original sources each.
3 verified stories tracked
Last mentioned: Jun 22, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 3 of 3 also mention Derm AI, the most common co-covered peer. ai-models accounts for 1 of the 3 tracked stories, while 2 other categories carry the remainder. The tracked stories average 2 original sources each. Skin Analytics appears in 3 tracked Cross-Sector stories from June 22, 2026.
Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Skin Analytics. Shared-story counts are live from our verified record — not editorial picks.
Derm AI, already proven on 230,000 NHS patients, now works on any smartphone, enabling pharmacy and GP-based skin checks that could cut the backlog of dermatology referrals.
Skin Analytics' Derm AI secures top European medical device approval with a landmark 99.8% melanoma detection rate, positioning it to reshape dermatology diagnostics.
Derm AI leverages deep learning to achieve 99.8% melanoma accuracy from standard smartphone photos, dropping the need for dedicated hardware and paving the way for widespread AI triage.
Source: Luke Chafer · Luke Chafer